Skip to main content

Currently Skimming:

Appendix D.3: Research Institute of Influenza
Pages 197-198

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 197...
... The institute reports that its principal activities include "exploration of molecular-genetic and phylogenetic features of prevailing and newly emerging viruses, identification of viral genetic determinants, and forecasting of evolutionary variability of influenza and other viral agents." For more than a decade, the institute has conducted investigations of carbon nanotubes and other nanomaterials. It collaborates with other local research institutions through the Center on Nanomedicine and Nanobiotechnology.
From page 198...
... • Development of prototype live-attenuated cold-adapted pandemic influenza vaccines based on avian strains, with the nongovernmental organization PATH Vaccine Solutions. • Development of a DNA vaccine based on a series of eukaryotic expression plasmids encoding the fusion proteins containing epitopes of influenza, with Cure Laboratory, Inc.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.